The antibody targets the mono-methylation at R128 of Histone H3.1, a core histone variant critical for nucleosome assembly and chromatin structure. Histone H3.1 is distinct from other H3 variants (e.g., H3.3) due to sequence differences and post-translational modifications (PTMs). R128 mono-methylation acts as an epigenetic signal, modulating chromatin accessibility and influencing transcriptional activation or repression depending on the cellular context .
Property | Details |
---|---|
Target | Mono-methylated R128 on Histone H3.1 |
Host | Rabbit or HEK293F cells (varies by vendor) |
Applications | Western blotting (WB), ELISA, Peptide array (PepArr) |
Species Reactivity | Human, Mouse |
Predicted Band Size | 15 kDa (observed in WB) |
The antibody is produced via recombinant technology, ensuring high specificity and reproducibility:
Cloning: Heavy and light chain genes encoding the HIST1H3A antibody are cloned into expression vectors .
Expression: Host cells (e.g., HEK293F) transfect vectors to produce and secrete the antibody .
Validation: Tested in ELISA and WB for functionality, with peptide arrays confirming target specificity .
Key Validation Data (from Abcam [EPR17898] antibody):
Application | Sample | Dilution | Observed Band |
---|---|---|---|
WB | HeLa cells (human) | 1:1000 | 15 kDa |
WB | NIH/3T3 cells (mouse) | 1:1000 | 15 kDa |
PepArr | Synthetic peptides | N/A | High affinity for R128me1 peptide |
R128 mono-methylation is implicated in chromatin state transitions, such as:
Transcriptional Activation: Associated with active chromatin regions .
Cellular Identity: May regulate differentiation and development .
Cancer Metastasis: Histone H3.1 dynamics (e.g., replacement by H3.3) are linked to epithelial-to-mesenchymal transition (EMT) in aggressive cancers .
Western Blotting: Detects endogenous H3.1 R128me1 in lysates (e.g., HeLa, NIH/3T3 cells) .
Peptide Arrays: Confirms specificity for R128me1 over other histone PTMs (e.g., H3K4me3, H3K27me3) .
ChIP-seq: While not directly tested for this antibody, related studies show H3.1 loss near transcription start sites during oxidative stress .
While the antibody itself does not directly study Histone H3.1’s redox properties, related research highlights its broader role:
The production process of the mono-methyl-histone H3.1 (R128) recombinant monoclonal antibody begins with the cloning of genes that encode the HIST1H3A antibody, encompassing both heavy and light chains. These cloned genes are incorporated into expression vectors, which are then introduced into host cells through transfection. The host cells are then responsible for producing and secreting the antibody. Following purification through affinity chromatography to ensure purity, the antibody undergoes comprehensive functionality testing in ELISA and WB applications, guaranteeing accurate detection of the human and mouse HIST1H3A proteins mono-methylated at R128.
Histone H3.1 mono-methylation at arginine 128 (R128) can promote either transcriptional activation or repression, depending on the specific cellular context and the proteins involved. H3.1 R128 mono-methylation serves as an epigenetic signal, indicating specific chromatin states and influencing essential cellular processes like differentiation, development, and cellular identity.
Histone H3.1 is a core component of nucleosomes. Nucleosomes play a crucial role in wrapping and compacting DNA into chromatin, thereby limiting DNA accessibility to cellular machinery that requires DNA as a template. Consequently, histones are central to the regulation of transcription, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated through a complex set of post-translational modifications of histones, collectively known as the histone code, and nucleosome remodeling.